MASSIVE BIOINFORMATICS ARGE TECHNOLOGIES JOINT STOCK COMPANY
Company Profile:
MASSIVE BIOINFORMATICS ARGE TECHNOLOGIES JOINT STOCK COMPANY is a technology and research and development (R&D) company, neither a factory nor a trader. It provides services and develops software/solutions in the field of bioinformatics.
Company Introduction:
MASSIVE BIOINFORMATICS ARGE TECHNOLOGIES JOINT STOCK COMPANY is a Turkish technology and research and development (R&D) enterprise dedicated to advancing the field of bioinformatics and genomics. The company specializes in developing sophisticated computational solutions, software, and platforms for the analysis of large-scale biological data. Their expertise encompasses areas such as DNA and RNA sequencing analysis, proteomics, metagenomics, and the application of artificial intelligence and machine learning to biological datasets. They offer services and tools that support scientific research, drug discovery, personalized medicine, agricultural biotechnology, and other life science applications. Through continuous innovation and a strong focus on R&D, Massive Bioinformatics aims to transform complex biological information into actionable insights, facilitating scientific breakthroughs and contributing to advancements in healthcare and biotechnology.
Enterprise Products
Based on available information, MASSIVE BIOINFORMATICS ARGE TECHNOLOGIES JOINT STOCK COMPANY produces and/or sells the following:
* **AI-powered clinical trial matching platform**
* **Drug repurposing solutions**
* **Biomarker discovery services**
* **Genomic data analysis tools**
* **Precision oncology solutions**
Business Registration Information:
Manager:
Selim Tuncer (CEO and Co-Founder)
Phone:
E-mail:
Official Website:
Address:
Bilkent Cyberpark C Blok No:16/B Bilkent Çankaya ANKARA / TURKEY
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.